Drugs / Runihol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02930161 | May 2016 → Oct 2018 | NAFLD1 | POLYSAN Scientific & Technological Pharmaceutical Company | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Runihol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02930161 ↗ |
| Route | Oral | “Intake of Runihol, 2 tablets orally” NCT02930161 ↗ |